Nooman Gilani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Nooman Gilani has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Francisco C Ramirez
2 shared publications- Richard Gerkin
University of Arizona College of Medicine-Phoenix
2 shared publications Adam C Randolph
1 shared publicationBilal Khan
Department of Gastroenterology, Phoenix VA Medical Center/Banner Good Samaritan Medical Center, Phoenix, Arizona 85012, USA
1 shared publicationDeepa K. Shah
1 shared publicationErin E Tharalson
1 shared publication
Latest Publications
- 1 October 2017
- Vol. 67 (10) , 1487-1492
Effectiveness of multidisciplinary approach in patients undergoing therapy for chronic hepatitis C.
To assess the effect of a multidisciplinary approach on the outcome of treatment for hepatitis C virus infection. This retrospective study was conducted at the gastroenterology division by primary care providers at Phoenix VA Healthcare system in Phoenix, Arizona, United States, and comprised clinical and laboratory data of all hepatitis C patients treated between November 2002 and December 2006. The patients were clinically evaluated to determine whether they were candidates for treatment with pegylated interferon a-2a or a-2b plus ribavirin. Patients were given detailed orientation prior to the therapy, and were closely monitored during the treatment. Of the 295 patients, 179(60.7%) received pegylated interferon a-2b and ribavirin and 116(39.3%) received pegylated interferon a-2a and ribavirin. Overall, 202(68.47%) had genotype 1 and 93 (31.52%) had non-genotype 1. Age range was 35 to 66 years (mean 51±8.51 and Mean BMI was 28.2±4.22), and the majority was Caucasian males who served in the Vietnam era. The overall sustained virological response was 120(40.7%). High sustained virological response was achieved among the participants.
- 1 October 2017
- Vol. 67 (10) , 1487-1492
Effectiveness of multidisciplinary approach in patients undergoing therapy for chronic hepatitis C.
To assess the effect of a multidisciplinary approach on the outcome of treatment for hepatitis C virus infection. This retrospective study was conducted at the gastroenterology division by primary care providers at Phoenix VA Healthcare system in Phoenix, Arizona, United States, and comprised clinical and laboratory data of all hepatitis C patients treated between November 2002 and December 2006. The patients were clinically evaluated to determine whether they were candidates for treatment with pegylated interferon a-2a or a-2b plus ribavirin. Patients were given detailed orientation prior to the therapy, and were closely monitored during the treatment. Of the 295 patients, 179(60.7%) received pegylated interferon a-2b and ribavirin and 116(39.3%) received pegylated interferon a-2a and ribavirin. Overall, 202(68.47%) had genotype 1 and 93 (31.52%) had non-genotype 1. Age range was 35 to 66 years (mean 51±8.51 and Mean BMI was 28.2±4.22), and the majority was Caucasian males who served in the Vietnam era. The overall sustained virological response was 120(40.7%). High sustained virological response was achieved among the participants.
- 28 February 2011
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 73 (2) , 403-405
String capsule endoscopy: a novel application for the preoperative identification of a small-bowel obscure GI bleeding source (with video)
- 28 February 2011
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 73 (2) , 403-405
String capsule endoscopy: a novel application for the preoperative identification of a small-bowel obscure GI bleeding source (with video)
- Open Access
- 1 October 2009
- Published by Elsevier in Annals of Hepatology
- Vol. 8 (4) , 359-363
The safety and feasibility of large volume paracentesis performed by an experienced nurse practitioner
- 1 October 2009
- Published by Elsevier in Annals of Hepatology
- Vol. 8 (4) , 359-363
Open AccessThe safety and feasibility of large volume paracentesis performed by an experienced nurse practitioner
- 18 August 2009
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 30 (6) , 597-602
Interferon‐induced retinopathy and its risk in patients with diabetes and hypertension undergoing treatment for chronic hepatitis C virus infection
Summary: Background Ocular complications are amongst many side‐effects of interferon based therapy for hepatitis C virus (HCV) infection. Some suggest that diabetic and hypertensive patients are at increased risk of these complications.Aim To determine the frequency of ophthalmological complications related to interferon use.Methods Retrospective analysis of patients undergoing HCV treatment with pegylated interferon α‐2a, α‐2b or consensus interferon plus ribavirin between 2005 and 2007. All patients underwent a baseline eye examination and any visual complaints during treatment prompted a repeat examination. Data recorded included HCV genotype, treatment duration, interferon type, pre‐treatment and on treatment visual complaints, known ocular pathology, and retinal findings at baseline and at follow‐up.Results Of 183 patients, 29 (16%) had diabetes and 85 (46%) had hypertension. Seventy‐one (38%) received interferon α‐2a, 100 (55%) α‐2b, and 12 (7%) consensus interferon. Seven (3.8%) had retinal changes on follow‐up and treatment was discontinued in 3 (1.6%). Of seven with ocular changes two had hypertension and one had both hypertension and diabetes.Conclusion The incidence of symptomatic retinopathy in HCV patients undergoing interferon therapy appears low and treatment cessation is rarely needed. Furthermore, patients with hypertension and diabetes may not be at higher risk for interferon‐induced retinopathy.
- 18 August 2009
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 30 (6) , 597-602
Interferon‐induced retinopathy and its risk in patients with diabetes and hypertension undergoing treatment for chronic hepatitis C virus infection
Summary: Background Ocular complications are amongst many side‐effects of interferon based therapy for hepatitis C virus (HCV) infection. Some suggest that diabetic and hypertensive patients are at increased risk of these complications.Aim To determine the frequency of ophthalmological complications related to interferon use.Methods Retrospective analysis of patients undergoing HCV treatment with pegylated interferon α‐2a, α‐2b or consensus interferon plus ribavirin between 2005 and 2007. All patients underwent a baseline eye examination and any visual complaints during treatment prompted a repeat examination. Data recorded included HCV genotype, treatment duration, interferon type, pre‐treatment and on treatment visual complaints, known ocular pathology, and retinal findings at baseline and at follow‐up.Results Of 183 patients, 29 (16%) had diabetes and 85 (46%) had hypertension. Seventy‐one (38%) received interferon α‐2a, 100 (55%) α‐2b, and 12 (7%) consensus interferon. Seven (3.8%) had retinal changes on follow‐up and treatment was discontinued in 3 (1.6%). Of seven with ocular changes two had hypertension and one had both hypertension and diabetes.Conclusion The incidence of symptomatic retinopathy in HCV patients undergoing interferon therapy appears low and treatment cessation is rarely needed. Furthermore, patients with hypertension and diabetes may not be at higher risk for interferon‐induced retinopathy.
- Open Access
- 18 March 2008
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 27 (11) , 1006-1016
Review article: gastrointestinal amyloidosis – clinical features, diagnosis and therapy
Summary: Background Amyloidosis is one of the unusual diseases about which a physician may not think when it is affecting the patient. During the last three decades, there has been an enormous progress in the understanding of the chemical nature, classification, pathogenesis, clinical features, diagnostic measures and therapy of this disorder.Aim To provide an updated review of amyloidosis affecting the gastrointestinal tract.Methods Review of current medical literature.Results Amyloid proteins (irrespective of the type) can deposit in various parts of the gastrointestinal tract and liver resulting in symptoms of abdominal pain, dysmotility, diarrhoea, gastrointestinal bleeding, hepatomegaly and even portal hypertension with its associated complications. Definitive diagnosis can only be made by histological examination of the affected organ. Disease modifying treatment with high‐dose chemotherapy followed by autologous stem‐cell transplantation has shown promise. Liver transplantation is an option for a select group of patients.Conclusions Suspicion of gastrointestinal amyloidosis in patients without known history of amyloidosis is difficult, but should be considered in those older than 30 years with unexplained diarrhoea, weight loss, autonomic dysfunction, malabsorption or proteinuria. While most gastrointestinal complications are managed symptomatically, causal therapy is reserved for a select few from various subtypes of this disorder.
- 18 March 2008
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 27 (11) , 1006-1016
Open AccessReview article: gastrointestinal amyloidosis – clinical features, diagnosis and therapy
Summary: Background Amyloidosis is one of the unusual diseases about which a physician may not think when it is affecting the patient. During the last three decades, there has been an enormous progress in the understanding of the chemical nature, classification, pathogenesis, clinical features, diagnostic measures and therapy of this disorder.Aim To provide an updated review of amyloidosis affecting the gastrointestinal tract.Methods Review of current medical literature.Results Amyloid proteins (irrespective of the type) can deposit in various parts of the gastrointestinal tract and liver resulting in symptoms of abdominal pain, dysmotility, diarrhoea, gastrointestinal bleeding, hepatomegaly and even portal hypertension with its associated complications. Definitive diagnosis can only be made by histological examination of the affected organ. Disease modifying treatment with high‐dose chemotherapy followed by autologous stem‐cell transplantation has shown promise. Liver transplantation is an option for a select group of patients.Conclusions Suspicion of gastrointestinal amyloidosis in patients without known history of amyloidosis is difficult, but should be considered in those older than 30 years with unexplained diarrhoea, weight loss, autonomic dysfunction, malabsorption or proteinuria. While most gastrointestinal complications are managed symptomatically, causal therapy is reserved for a select few from various subtypes of this disorder.
- Open Access
- 1 January 2008
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 14 (22) , 3518-3522
Prevalence of Barrett’s esophagus in patients with moderate to severe erosive esophagitis
Prevalence of Barrett’s esophagus in patients with moderate to severe erosive esophagitis
- 1 January 2008
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 14 (22) , 3518-3522
Open AccessPrevalence of Barrett’s esophagus in patients with moderate to severe erosive esophagitis
Prevalence of Barrett’s esophagus in patients with moderate to severe erosive esophagitis
- 1 January 2007
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 13 (8) , 1268-1270
Endoscopic resection of an ampullary carcinoid presenting with upper gastrointestinal bleeding: A case report and review of the literature
Ampullary carcinoid is a rare tumor that can present with gastrointestinal bleeding, obstructive jaundice or pancreatitis. Some of these tumors are associated with Von Recklinghausen disease. The usual surgical options are a biliary-enteric anastomosis, Whipple procedure or rarely a local resection. The mean survival does not appear to be much different after a pancreaticoduodenectomy versus local surgical excision. We report a very rare case of a non-metastatic ampullary carcinoid causing upper gastrointestinal bleeding, which was managed by endoscopic ampullectomy.
- 1 January 2007
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 13 (8) , 1268-1270
Endoscopic resection of an ampullary carcinoid presenting with upper gastrointestinal bleeding: A case report and review of the literature
Ampullary carcinoid is a rare tumor that can present with gastrointestinal bleeding, obstructive jaundice or pancreatitis. Some of these tumors are associated with Von Recklinghausen disease. The usual surgical options are a biliary-enteric anastomosis, Whipple procedure or rarely a local resection. The mean survival does not appear to be much different after a pancreaticoduodenectomy versus local surgical excision. We report a very rare case of a non-metastatic ampullary carcinoid causing upper gastrointestinal bleeding, which was managed by endoscopic ampullectomy.